Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
  • Listen Now Playing Listen
AirTalk

The latest in cancer treatment

A chemotherapy machine.
A chemotherapy machine.
(
Jan Charles Linus Ekenstam/Flickr (cc by-nc-nd)
)
Listen 34:21
The latest in cancer treatment
According to the 2011 American Cancer Society Report there is a continued decline in overall cancer deaths in the U.S. African American and Hispanic men showed the largest annual decreases in cancer death rates during this time period, 2.6% and 2.5%, respectively and lung cancer death rates showed a significant decline in women after continuously increasing since the 1930s. Dr. Michael Friedman, the President and CEO at the City of Hope Cancer Center joins Larry Mantle to discuss the most promising research in cancer treatment presented at the annual meeting of the American Society Clinical Oncology. Those developments include new drugs for metastatic melanoma, new tests for gene mutations in lung cancer that could lead to greater specificity in treatment, new research showing the success of an estrogen inhibiting drug used in invasive breast cancer and an enzyme blocking drug that improves recurrence rates in people with stomach cancer.

According to the 2011 American Cancer Society Report there is a continued decline in overall cancer deaths in the U.S. African American and Hispanic men showed the largest annual decreases in cancer death rates during this time period, 2.6% and 2.5%, respectively and lung cancer death rates showed a significant decline in women after continuously increasing since the 1930s. Dr. Michael Friedman, the President and CEO at the City of Hope Cancer Center joins Larry Mantle to discuss the most promising research in cancer treatment presented at the annual meeting of the American Society Clinical Oncology. Those developments include new drugs for metastatic melanoma, new tests for gene mutations in lung cancer that could lead to greater specificity in treatment, new research showing the success of an estrogen inhibiting drug used in invasive breast cancer and an enzyme blocking drug that improves recurrence rates in people with stomach cancer.

Guest:

Michael Friedman, MD, President and CEO at the City of Hope Cancer Center in Duarte